StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Wednesday morning. The firm issued a buy rating on the stock.
Mannatech Stock Down 4.3 %
Shares of MTEX opened at $11.53 on Wednesday. The business’s 50 day moving average is $11.84 and its 200 day moving average is $9.07. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Mannatech has a 12-month low of $6.75 and a 12-month high of $16.49. The company has a market capitalization of $21.67 million, a PE ratio of -14.23 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The company had revenue of $31.73 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- Insider Buying Explained: What Investors Need to Know
- Nebius Group: Market Overreaction or Real AI Disruption?
- The Basics of Support and Resistance
- The Best Way to Invest in Gold Is…
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.